These findings suggest that reduced-intensity bone marrow conditioning may be sufficient for full engraftment of allogeneic donor (78) or autologous gene-corrected HSCs, although this approach might be avoided if the DBA recipient harbors hematopoietic cell clones with somatic mutations of TP53 or other leukemia-associated genes. The gene discussed is TP53; the disease is leukemia.